...
首页> 外文期刊>Prion >Poly-L-histidine inhibits prion propagation in a prion-infected cell line
【24h】

Poly-L-histidine inhibits prion propagation in a prion-infected cell line

机译:聚-L-组氨酸抑制病毒感染的细胞系中病毒的繁殖

获取原文
           

摘要

Transmissible spongiform encephalopathies (TSEs) are a group of lethal neurodegenerative diseases involving the structural conversion of cellular prion protein (PrPC) into the pathogenic isoform (PrPSc) for which no effective treatment is currently available. Previous studies have implicated that a polymeric molecule with a repeating unit, such as pentosane polysulfate and polyamidoamide dendrimers, exhibits a potent anti-prion activity, suggesting that poly-(amino acid)s could be a candidate molecule for inhibiting prion propagation. Here, by screening a series of poly-(amino acid)s in a prion-infected neuroblastoma cell line (GTFK), we identified poly-L-His as a novel anti-prion compound with an IC50 value of 1.8?μg/mL (0.18?μM). This potent anti-prion activity was specific to a high-molecular-weight poly-L-His and absent in monomeric histidine or low-molecular-weight poly-L-His. Solution NMR data indicated that poly-L-His directly binds to the loop region connecting Helix 2 and Helix 3 of PrPC and sterically blocks the structural conversion toward PrPSc. Poly-L-His, however, did not inhibit prion propagation in a prion-infected mouse when administered intraperitoneally, suggesting that the penetration of blood-brain barrier and/or the chemical stability of this polypeptide must be addressed before its application in vivo. Taken together, this study revealed the potential use of poly-L-His as a novel treatment against TSEs. (203 words).
机译:传染性海绵状脑病(TSE)是一组致命的神经退行性疾病,涉及细胞of病毒蛋白(PrPC)向病原体(PrPSc)的结构转化,目前尚无有效的治疗方法。先前的研究暗示具有重复单元的聚合分子,例如戊烷多硫酸盐和聚酰胺酰胺树状大分子,表现出有效的抗-病毒活性,这表明聚氨基酸可能是抑制病毒传播的候选分子。在这里,通过在感染pr病毒的神经母细胞瘤细胞系(GTFK)中筛选一系列聚氨基酸,我们确定了聚L-His是一种新型抗anti病毒化合物,IC50值为1.8?g / mL。 (0.18?M)。这种有效的抗-病毒活性对高分子量的聚-L-His具有特异性,而在单体组氨酸或低分子量的聚-L-His中则不存在。溶液NMR数据表明,聚-L-His直接结合于连接PrPC的螺旋2和螺旋3的环区域,并在空间上阻止了向PrPSc的结构转化。但是,当腹膜内给药时,聚-L-His不会抑制病毒感染的小鼠中ion病毒的繁殖,这表明在体内应用该多肽之前必须解决血脑屏障的渗透和/或化学稳定性。综上所述,这项研究揭示了聚L-His作为针对TSE的新型疗法的潜在用途。 (203个字)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号